000 | 01796 a2200529 4500 | ||
---|---|---|---|
005 | 20250515154302.0 | ||
264 | 0 | _c20090608 | |
008 | 200906s 0 0 eng d | ||
022 | _a1945-7170 | ||
024 | 7 |
_a10.1210/en.2008-1149 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMorgan, D | |
245 | 0 | 0 |
_aAssociation of NAD(P)H oxidase with glucose-induced insulin secretion by pancreatic beta-cells. _h[electronic resource] |
260 |
_bEndocrinology _cMay 2009 |
||
300 |
_a2197-201 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGlucose _xmetabolism |
650 | 0 | 4 |
_aHydrogen Peroxide _xmetabolism |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 | _aInsulin Secretion |
650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
650 | 0 | 4 |
_aNADPH Oxidases _xantagonists & inhibitors |
650 | 0 | 4 |
_aOnium Compounds _xpharmacology |
650 | 0 | 4 |
_aOxidation-Reduction _xdrug effects |
650 | 0 | 4 |
_aRNA, Small Interfering _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
700 | 1 | _aRebelato, E | |
700 | 1 | _aAbdulkader, F | |
700 | 1 | _aGraciano, M F R | |
700 | 1 | _aOliveira-Emilio, H R | |
700 | 1 | _aHirata, A E | |
700 | 1 | _aRocha, M S | |
700 | 1 | _aBordin, S | |
700 | 1 | _aCuri, R | |
700 | 1 | _aCarpinelli, A R | |
773 | 0 |
_tEndocrinology _gvol. 150 _gno. 5 _gp. 2197-201 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/en.2008-1149 _zAvailable from publisher's website |
999 |
_c18595323 _d18595323 |